Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
On-demand webinar: The biosimilar breakthrough in adoption and affordability
Learn how biosimilars are reshaping the prescription drug affordability landscape. View the 20-minute on-demand webinar about the biosimilar breakthrough in adoption and affordability, hosted by the Evernorth Research Institute.
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
In this episode of "Health Unscripted," Eva Borden, president of Evernorth Behavioral Health, emphasizes the need for U.S. employers to leverage their influence through health insurance, workplace culture, and community engagement to change the crisis trajectory.
Plan sponsors can support expecting mothers aged 35+ with prenatal care, despite long-standing assumptions their pregnancies are high risk.
Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.
